SCHEDULE: Manulife Entities Adjust Veeco Instruments Stake

Manulife Financial Corporation and its subsidiaries have filed an amended Schedule 13G, reporting a combined beneficial ownership of 4.24% in Veeco Instruments Inc. common stock.

Summary

• Manulife Financial Corporation, Manulife Investment Management Limited (MIML), and Manulife Investment Management (US) LLC (MIM (US)) filed an Amendment No. 3 to Schedule 13G for Veeco Instruments Inc.
• The filing reports beneficial ownership as of December 31, 2025.
• Manulife Investment Management (US) LLC has reduced its beneficial ownership in Veeco Instruments Inc. to 2,531,978 shares, representing 4.21% of the common stock, down from a previous stake that would have been above 5% to trigger the initial 13G filing.
• Manulife Investment Management Limited beneficially owns 18,615 shares, representing 0.03% of Veeco Instruments Inc.'s common stock.
• Manulife Financial Corporation, as the parent holding company, may be deemed to beneficially own the shares held by MIM (US) and MIML.
• The total beneficial ownership by the Manulife entities is 2,550,593 shares, which is approximately 4.24% of the 60,162,510 shares outstanding as of October 30, 2025.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative signal for Veeco Instruments Inc. as a significant institutional investor has reduced its stake below the 5% threshold, potentially indicating a re-evaluation of its investment.

Positives

• Manulife entities maintain a significant, albeit reduced, investment in Veeco Instruments Inc., indicating continued interest.

Negatives

• Manulife Investment Management (US) LLC has reduced its beneficial ownership in Veeco Instruments Inc. from above 5% to 4.21%, which could be interpreted as a decrease in conviction or a portfolio rebalancing by a significant institutional investor.

Future Outlook

No forward-looking statements or guidance from Veeco Instruments Inc. are provided in this filing.

Industry Context

StockSavvy.ai notes that institutional investors frequently adjust their positions in public companies as part of routine portfolio management, rebalancing, or in response to market conditions and investment strategies. A reduction in stake by a major institutional holder like Manulife, while not necessarily a negative signal for the issuer's fundamentals, warrants attention as it could reflect a shift in investment thesis or a reallocation of capital across their diverse portfolios.

Comparison to Industry Standards

• This filing is a routine disclosure of beneficial ownership and does not contain information suitable for direct comparison to industry-specific operational or financial benchmarks. It reflects an institutional investor's portfolio allocation decision rather than the issuer's performance against peers like Applied Materials or Lam Research.

Stakeholder Impact

• The reduction in beneficial ownership by Manulife entities could be perceived by shareholders as a slight decrease in institutional confidence, potentially influencing investor sentiment. No direct impact on employees, customers, suppliers, or creditors is indicated by this filing.

Key Dates

Recommendation

The filing indicates a reduction in beneficial ownership by a significant institutional investor, Manulife Investment Management (US) LLC, bringing its stake below the 5% threshold. While this is generally viewed as a negative signal, it's a portfolio adjustment by an institutional investor and does not provide direct insight into Veeco Instruments Inc.'s operational performance or future prospects. Investors should hold and monitor for further developments or fundamental changes in the company's business.

Keywords

Veeco Instruments Inc., VEECO, Manulife Financial Corporation, Manulife Investment Management, Schedule 13G, Beneficial Ownership, Institutional Investment, Common Stock, SEC Filing